Optiver Holding
JBIO

Optiver Holding’s Jade Biosciences JBIO Stock Holding History

Optiver Holding’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.31K Buy
+104
New +$2.17K ﹤0.01% 2268

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Optiver Holding's JBIO Position: Q2 2026 in Review

Optiver Holding opened a new position in Jade Biosciences (JBIO) in Q2 2026: 104 shares worth $2.31K. The stake represents ﹤0.01% of the portfolio and ranks #2268 among its holdings.

154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Optiver Holding held 104 shares of Jade Biosciences worth $2.31K as of Q2 2026.
  • Jade Biosciences was a new Optiver Holding position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2268 holding.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.